Patent · US Active

Epinephrine spray formulations

US11571384B2 · kind B2 · utility

2Cited by
4References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2018
Grant dateFeb 7, 2023
Priority date
Expiry dateJun 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.